Home » Stocks » Tricida

Tricida, Inc. (TCDA)

Stock Price: $26.93 USD 0.19 (0.71%)
Updated Jul 8, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.35B
Revenue (ttm) n/a
Net Income (ttm) -213.03M
Shares Out 49.95M
EPS (ttm) -4.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 8, 2020
Last Price $26.93
Previous Close $26.74
Change ($) 0.19
Change (%) 0.71%
Day's Open 26.77
Day's Range 26.26 - 26.97
Day's Volume 201,988
52-Week Range 18.03 - 44.30

More Stats

Market Cap 1.35B
Enterprise Value 1.13B
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 49.95M
Float 26.83M
EPS (basic) -4.32
EPS (diluted) -4.31
FCF / Share -3.18
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4.74M
Short Ratio 9.03
Short % of Float 28.33%
Beta 1.57
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 6.67
Revenue n/a
Operating Income -213.96M
Net Income -213.03M
Free Cash Flow -158.37M
Net Cash 215.44M
Net Cash / Share 4.31
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -48.97%
ROE -118.66%
ROIC -55.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(88.15% upside)
Current: 26.93
Target: 50.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-179-104-47.12-27.18
Net Income-177-103-41.29-28.65
Shares Outstanding47.5222.152.141.83
Earnings Per Share-3.72-4.64-19.32-15.69
Operating Cash Flow-130-94.86-40.40-23.12
Capital Expenditures-1.42-0.86-1.00-0.25
Free Cash Flow-131-95.71-41.41-23.36
Cash & Equivalents30824167.5126.45
Total Debt68.2338.07--
Net Cash / Debt24020367.5126.45
Book Value264195-88.04-47.63
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tricida, Inc.
Country United States
Employees 141
CEO Gerrit Klaerner

Stock Information

Ticker Symbol TCDA
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TCDA
IPO Date June 28, 2018


Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.